AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
BCRX holding history
Biocryst Pharmaceuticals Inc in every 13F filed by AlphaCentric Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
BCRX overviewAll 13F holders of BCRXFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −675,000−100.0% | Sold out | Holders |
| Q2 2024 | 675,000 | $4.17M | 3.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 675,000 | $3.43M | 2.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 675,000 | $4.04M | 2.7% | +26,000+4.0% | Added | Holders |
| Q3 2023 | 649,000 | $4.59M | 2.6% | +79,000+13.9% | Added | Holders |
| Q2 2023 | 570,000 | $4.01M | 2.2% | +150,500+35.9% | Added | Holders |
| Q1 2023 | 419,500 | $3.50M | 2.4% | +294,500+235.6% | Added | Holders |
| Q4 2022 | 125,000 | $1.44M | 1.4% | +55,000+78.6% | Added | Holders |
| Q3 2022 | 70,000 | $882.0K | 0.9% | – | No prior filing | Holders |
| Q1 2022 | – | – | – | – | Not filed | Holders |
| Q4 2021 | 17,500 | $242.0K | 0.1% | +17,500 | New | Holders |